NCT05639153 2026-04-13
A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors
Zhejiang Doer Biologics Co., Ltd.
Phase 1 Terminated
Zhejiang Doer Biologics Co., Ltd.
Elevation Oncology
Pfizer
sigma-tau i.f.r. S.p.A.